tau-targeted PROTAC protein degrader program (Arvinas)

N/A

Report date: 2025/03/20 09:31:04
NME

Base Information

Drug Nametau-targeted PROTAC protein degrader program (Arvinas)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUbiquitin-protein ligases modulatorsMicrotubule-associated protein tau inhibitors
TargetsMicrotubule-associated protein tauUbiquitin-protein ligases
Therapy Area/IndicationsAlzheimer DiseaseSupranuclear Palsy, Progressive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArvinas Inc
China Registration ClassN/A

Develop Information

Active CompaniesArvinas Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseSupranuclear Palsy, Progressive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A